Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Unilabs’ Patients get faster diagnosis of sepsis through the project SMARTDIAGNOS

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark...

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by...

Philips received FDA 510(k) clearance for SmartHeart, which happens...
Unilabs Sweden is a key player to the EU project "SMARTDIAGNOS- Next Generation sepsis diagnosis technology", which provides rapid diagnostics and better conditions for treatment for patients with blood poisoning.
 
Blood poisoning, known as sepsis, is a potentially fatal immune response of the human body, often caused by bacterial or fungal infection. Early diagnosis is crucial for proper treatment.
 
"Unilabs eagerly looks forward to contributing to this important project", says Helena Enroth, development manager Molecular Unilabs Skövde and adjunct professor at the University of Skövde.
 
Ten partners consisting of companies, institutions and universities, runs the SMARTDIAGNOS- project simultaneously. The 4-years running project has received funding from the EU's "Horizon 2020 Research and Innovation Programme under the grant agreement No. 687 697 ". The project started om February 1, 2016.
 
SMARTDIAGNOS will provide fast and accurate sepsis diagnosis, with the ability to reduce morbidity and mortality by up to 20%. 
MEDICAL FAIR ASIA 2026

Latest stories

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark for Abbott Instinct Sensor

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by Philips Gets Clearance

Philips received FDA 510(k) clearance for SmartHeart, which happens...

Medtronic Neurovascular Portfolio Strengthens with Scientia

Medtronic, on March 10, 2026, announced a definitive agreement...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »